Argenx
ARGX
#625
Rank
ยฃ24.77 B
Marketcap
ยฃ408.67
Share price
1.38%
Change (1 day)
-3.24%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : ยฃ3.65 B

According to Argenx 's latest financial reports the company's total assets are ยฃ3.65 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2022-12-31ยฃ2.59 B23.01%
2021-12-31ยฃ2.10 B3.19%
2020-12-31ยฃ2.04 B49.81%
2019-12-31ยฃ1.36 B129.33%
2018-12-31ยฃ0.59 B50.38%
2017-12-31ยฃ0.39 B316.6%
2016-12-31ยฃ94.82 M156.43%
2015-12-31ยฃ36.98 M-33.53%
2014-12-31ยฃ55.63 M92.56%
2013-12-31ยฃ28.89 M54.16%
2012-12-31ยฃ18.74 M-29.77%
2011-12-31ยฃ26.68 M152.39%
2010-12-31ยฃ10.57 M